The latest articles from BioStock
» BioStock Studio: Targinta provides business update ahead of spin-off
» CombiGene is sailing with the wind
» Idogen's CEO looks forward to the next step in hemophilia
» PHI on sales strategies for the China market
» Karolinska Development on the offensive with share issue
Read BioStock's newsletter for v.3 here.
Cereno Scientific announces that a milestone has been reached in the preclinical program CS014. Read more.
presents the company's technology platform at a scientific congress. Read more.
Ecti Research evaluating further use of MFA-370 in association with Sahlgrenska Academy. Read moreThe company has appointed Dr. Austin Smith as the new Chief Medical Officer. Read more.
Sedana Medical announces that National Institute for Health and Care Excellence (NICE) has issued positive guidelines recommending Sedaconda ACD. Read more.
Genetic Analysis announces the first commercial sale of GA-map Dysbiosis Test version 2. Read more.
ObsteCare visiting Sheikh Khalifa Medical Center in Ajman with potential distributors. Read more.
BergenBio and Oslo University Hospital will study Bemcentinib in patients with COVID-19. Read more.
Recipharm has signed an agreement regarding vaccine manufacturing. Read more.
SensoDetect has renewed its ISO 13485:2016 certification during audit. Read more.
AlzeCure Pharmas presentation and records from Symposium on Pharmaceutical Profiling in Drug Discovery and Development are available on the company's website. Read more.
Senzime announces a published study showing results in favor of TetraGraph EMG. Read more.
Invitation to presentation of BioArctics Year-end report for January – December 2021. Read more.
Year-end reports:
Reports:
ArcticZymes Technologies C-ROW NextCell Pharma
News received since yesterday lunch:
Transport has granted permission to implement the merger plan between Coegin Pharma and Follicum and publication of a preliminary timetable for the merger with Follicum. Read more.
Evaxion Biotech announced the publication of clinical data regarding EVX-01. Read more.
The first patients have been recruited to the phase III study with Lipidors AKP02 for the treatment of plaque psoriasis. Read more.
Brighter announced the outcome of the rights issue. Read more.
Smell announced that they had sold two Miri's HMA to the center Cincinnati Children's, USES. Read more.
Polymer Factory informed about research regarding dendrites. Read more.
CS Medicas The chairman of the board has purchased shares in the company. Read more.
Glycorex Transplant will present at Aktiedagen Lund on January 31st. Read more.
ArcticZymes Technologies invites you to the presentation of the results for the fourth quarter. Read more.
Boule Diagnostics has invited to the presentation of the year-end report 2021. Read more.
Nordic Nanovector published financial calendar. Read more.
Coloplast informed about insider transactions. Read more.
This morning's losers: Orexo -12,8%, Aino Health -11,4%, Biosergen -11%, Idogen -6,4%, Eurocine Vaccines -6,1%
Index: OMXS30 2268 -0,77%, Healthcare -0,84%
